Table 2 Occurrence of the selected outcomes of interest in the included studies.
Authors | Nr. of patients with at least one revision surgery | Nr. of patients with at least one shunt dysfunction/obstruction | Nr. of patients with at least one infection-related complication | Nr. of death | ||||
|---|---|---|---|---|---|---|---|---|
VPS | VAS | VPS | VAS | VPS | VAS | VPS | VAS | |
Ignelzi and Kirsch | 67 (56%) | 85 (48%) | 59 (52%) | 74 (42%) | 7 (6%) | 11 (6%) | NA | NA |
Olsen and Frykberg | 59 (85%) | 56 (54%) | 60 (87%) | 71 (69%) | 16 (23%) | 31 (30%) | 8 (13%) | 35 (34%) |
Fernell et al.% | NA | NA | NA | NA | NA | NA | 7 (5%) | 8 (10%) |
Keucher and Maeley% | NA | NA | NA | NA | NA | NA | 9 (11%) | 15 (10%) |
Lam and Villemure | 28 (38%) | 16 (33%) | 25 (34%) | 8 (16%) | NA | NA | NA | NA |
Borgbjerg et al | 141(38%) | 264 (51%) | NA | NA | NA | NA | NA | NA |
McGovern et al | 17 (11%) | 10 (33%) | 14 (9%) | 2 (7%) | 3 (2%) | 0 (0%) | NA | NA |
Hung et al | 100 (29%) | 16 (11%) | 53 (15%) | 10 (7%) | 10 (3%) | 2 (1%) | NA | NA |
Rymarczuk et al | 248 (54%) | 34 (40%) | NA | NA | 18 (4%) | 0 (0%) | NA | NA |
